<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05063019</url>
  </required_header>
  <id_info>
    <org_study_id>202100965A3</org_study_id>
    <nct_id>NCT05063019</nct_id>
  </id_info>
  <brief_title>Role of Magnetic Resonance Enterography for Predicting Peritoneal Cancer Index</brief_title>
  <official_title>Adding Value of Magnetic Resonance Imaging and Magnetic Resonance Enterography for the Pre-operative Assessment of Imaging Peritoneal Cancer Index in Patients With Peritoneal Carcinomatosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chang Gung Memorial Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chang Gung Memorial Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective observational study which will recruit 90 participants over a&#xD;
      three-year period to investigate whether adding magnetic resonance imaging and enterography&#xD;
      to routine computed tomography study can better predict the extend of peritoneal&#xD;
      carcinomatosis over computed tomography alone.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Hyperthermic Intraperitoneal Chemotherapy (HIPEC) is a new option for patients with&#xD;
      peritoneal carcinomatosis and the effectiveness of HIPEC depends on the extend of disease.&#xD;
      Currently, pre-operative imaging peritoneal cancer index (PCI) is used to predict the&#xD;
      intraoperative tumor extend and completeness of cytoreduction. However, the investigators'&#xD;
      previous study and literature review show that imaging PCI usually underestimated&#xD;
      intraoperative PCI, resulting in subsequent Open-Close operation. The investigators&#xD;
      hypothesize that magnetic resonance imaging (MRI) is a better predictor of the&#xD;
      intra-operative PCI than computed tomography (CT), and MR Enterography can better represent&#xD;
      tumor deposits in the small intestine. This study aims to test whether the addition of MRI&#xD;
      and MR Enterography to CT study improves the prediction performance of the intraoperative PCI&#xD;
      and completeness of optimal cytoreduction over CT alone.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2021</start_date>
  <completion_date type="Anticipated">August 31, 2024</completion_date>
  <primary_completion_date type="Anticipated">August 31, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Predicting intraoperative PCI scores for patients with peritoneal carcinomatosis, using MR Enterography and CT</measure>
    <time_frame>36 months</time_frame>
    <description>The Sugarbaker's Peritoneal Cancer Index scores according to the MR enterography and CT images will be calculated pre-operatively and will be compared to the standard PCI scores obtained during operation. Basically, the scoring system divides the abdominopelvic cavity into 13 separate regions, and each region is scored 0-3 points as follows: 0 point, the absence of tumor; 1 point, tumors &lt; 0.5 cm in diameter; 2 points, tumors 0.5-5 cm in diameter; 3 points, tumors &gt; 5 cm in diameter.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Hyperthermic Intraperitoneal Chemotherapy</condition>
  <condition>Cytoreductive Surgery</condition>
  <condition>Peritoneal Carcinomatosis</condition>
  <arm_group>
    <arm_group_label>Magnetic resonance imaging and enterography following computed tomography</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Magnetic resonance imaging and enterography will be performed after computed tomography but before surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>MRI</intervention_name>
    <description>Magnetic resonance imaging and enterography before surgery</description>
    <arm_group_label>Magnetic resonance imaging and enterography following computed tomography</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with peritoneal carcinomatosis diagnosed by computed tomography&#xD;
&#xD;
          -  Schedule for operation at our institute&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age &lt; 20 years old&#xD;
&#xD;
          -  Renal function impairment or acute renal failure&#xD;
&#xD;
          -  Contraindications for magnetic resonance imaging&#xD;
&#xD;
          -  Primary tumor not origins from colorectal cancer, gastric cancer or ovarian cancer&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chia-Ni Lin, MA</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chang Gung Memorial Hospital, Chiayi, Taiwan</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Chia-Ni Lin, MA</last_name>
    <phone>+886 5 3621 000</phone>
    <phone_ext>2627</phone_ext>
    <email>lcn6979@cgmh.org.tw</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Li-Wen Lee, MD, PhD</last_name>
    <phone>+886 5 3621 000</phone>
    <phone_ext>2627</phone_ext>
    <email>m4572@cgmh.org.tw</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Chang Gung Memorial Hospital</name>
      <address>
        <city>Chiayi City</city>
        <zip>61363</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chia-Ni Lin, MA</last_name>
      <phone>+886 5 3621 000</phone>
      <phone_ext>2627</phone_ext>
      <email>lcn6979@cgmh.org.tw</email>
    </contact>
    <contact_backup>
      <last_name>Li-Wen Lee, MD, PhD</last_name>
      <phone>+886 5 3621 000</phone>
      <phone_ext>2627</phone_ext>
      <email>m4572@cgmh.org.tw</email>
    </contact_backup>
    <investigator>
      <last_name>Chia-Ni Lin, MA</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Li-Wen Lee, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 13, 2021</study_first_submitted>
  <study_first_submitted_qc>September 22, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 30, 2021</study_first_posted>
  <last_update_submitted>October 8, 2021</last_update_submitted>
  <last_update_submitted_qc>October 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Hyperthermic Intraperitoneal Chemotherapy</keyword>
  <keyword>Cytoreductive Surgery</keyword>
  <keyword>Peritoneal Cancer Index</keyword>
  <keyword>Magnetic Resonance Enterography</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma</mesh_term>
    <mesh_term>Peritoneal Neoplasms</mesh_term>
    <mesh_term>Hyperthermia</mesh_term>
    <mesh_term>Fever</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Individual participant data will not be available to other researchers.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

